StreetAlpha.app
Home › Stocks › VRAX

Virax Biolabs Group Ltd (VRAX)

Members
LATEST PRICE

Virax Biolabs makes diagnostic substances used in medical testing, based in Lanarkshire, United Kingdom. VRAX reports earnings on Wed, Dec 2, 2026.

Prices, price targets and earnings estimates for VRAX are shown to AI Starter and AI Pro members. Ratings, flow and news are open to everyone.See plans
AI Auto Pilots
Is VRAX in one of our four AI portfolios? Sign in free to see
Next report
Dec 2
2026 · Time not announced
Consensus EPS forecast
EPS and revenue estimates
Year-ago EPS
Same quarter last year
Options-implied move
Move priced in by options
Analyst consensus
—
No ratings in 90 days
Loading…

Seasonality

How VRAX has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2022.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D

No whale options trades in VRAX in the last 90 days.

Loading…

AI Auto Pilots

Paper trading

StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether VRAX is in one of them and how their past VRAX trades turned out.

VRAX in the AI portfolios
Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered VRAX in an article yet. Here's the latest on the wider market.

About Virax Biolabs Group

Virax Biolabs Group makes diagnostic substances, the materials used in medical tests carried out both outside the body and inside it. The company is based in Lanarkshire, in the United Kingdom, and operates in the medical diagnostics field. Its work centers on medical testing, and its customers are organizations that carry out diagnostic testing.

Headquarters
Lanarkshire, United Kingdom